INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 422m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago
Corporate insider
KL

Kieffer Tara Lynn

Chief Product Strategy OfficerCIK 0001834835

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score40
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F$46K
3,257 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ENANTA PHARMACEUTICALS INCChief Product Strategy Officer · Nov 26, 2025
9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A
—
1,575 sh
Feb 12, 2026
Feb 13, 2026
traded Feb 12, 2026
+1d
SEC FORM 4

Evidence

9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
4,987 sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

40
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Open-market sale
SELL$30K
2,106 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC FORM 4

Evidence

9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F$11K
753 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC FORM 4

Evidence

9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
100.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC FORM 4

Evidence